MNTA
Momenta Pharmaceuticals, Inc.
MNTA
MNTA
Delisted
MNTA was delisted on the 30th of September, 2020.
211 hedge funds and large institutions have $5.44B invested in Momenta Pharmaceuticals, Inc. in 2020 Q3 according to their latest regulatory filings, with 85 funds opening new positions, 46 increasing their positions, 64 reducing their positions, and 111 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
23% less first-time investments, than exits
New positions opened: 85 | Existing positions closed: 111
28% less repeat investments, than reductions
Existing positions increased: 46 | Existing positions reduced: 64
Holders
211
Holding in Top 10
16
Calls
$140M
Puts
$70.9M
Top Buyers
| 1 | +$257M | |
| 2 | +$123M | |
| 3 | +$102M | |
| 4 |
OP
Omni Partners
London,
United Kingdom
|
+$82M |
| 5 |
AAM
Alpine Associates Management
Palm Beach,
Florida
|
+$75.4M |
Top Sellers
| 1 | -$260M | |
| 2 | -$242M | |
| 3 | -$160M | |
| 4 |
RG
Redmile Group
San Francisco,
California
|
-$157M |
| 5 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$84.2M |